Skip to main content

IMIBIC Fellowship Programme for Personalised and Precision Medicine

Deliverables

Link to Euraxess website for each call for proposals

Link to Euraxess website for each call for proposals - Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Searching for OpenAIRE data...

Publications

In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer

Author(s): Juan M Jiménez-Vacas; Antonio J Montero-Hidalgo; Enrique Gómez-Gómez; Antonio C Fuentes-Fayos; Francisco Ruiz-Pino; Ipek Guler; Antonio Camargo; Francisco J Anglada; Julia Carrasco-Valiente; Manuel Tena-Sempere; André Sarmento-Cabral; Justo P Castaño; Manuel D Gahete; Raúl M Luque
Published in: The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 12, December 2021, 2021, Page(s) e4956–e4968, ISSN 1945-7197
Publisher: Oxford University Press
DOI: 10.1210/clinem/dgab516

Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool

Author(s): Herrero-Aguayo, Vicente; Sáez-Martínez, Prudencio; Jiménez-Vacas, Juan M; Moreno-Montilla, M Trinidad; Montero-Hidalgo, Antonio J; Pérez-Gómez, Jesús M; López-Canovas, Juan L; Porcel-Pastrana, Francisco; Carrasco-Valiente, Julia; J Anglada, Francisco; Gómez-Gómez, Enrique; Yubero-Serrano, Elena M; Ibañez-Costa, Alejandro; Herrera-Martínez, Aura D; Sarmento-Cabral, André; D Gahete, Man
Published in: Molecular Therapy Nucleic Acids, 27, 2022, Page(s) 1164-1178, ISSN 2162-2531
Publisher: Nature Publishing Group
DOI: 10.1016/j.omtn.2022.02.010

Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches

Author(s): Alexander Batista Duharte; Fakhri Hassouneh; Pablo Alvarez-Heredia; Alejandra Pera; Rafael Solana
Published in: Pharmaceutics, 14, 1721, 2022, ISSN 1999-4923
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14081721